Tuesday, December 06, 2016 1:55:24 PM
Video: https://www.rte.ie/news/2016/1205/836753-melanoma-cancer-cork-trial/
Updated / Dec. 5, 2016
Around 30 patients suffering from advanced melanoma cancer are being enrolled in a clinical trial in Cork, with early results indicating improved survival rates.
The trial involves a combination of two existing treatments.
Doctors are being encouraged to refer suitable patients for inclusion in the clinical trial, which is being offered by Cork Cancer Research Centre at Cork University Hospital.
Scientists believe that delivering an electrical pulse or shock directly to the tumour, along with an immunotherapy drug called IPI and low-dose chemotherapy will improve survival rates for advanced melanoma cancer patients.
Doctors involved in the clinical trial believe the new treatment will be widely adopted and have described it as one of the first of its kind in the world.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM